IL67995A - Pyrido(3,4-h)psoralen derivatives,their preparation and pharmaceutical and cosmetic compositions containing them - Google Patents
Pyrido(3,4-h)psoralen derivatives,their preparation and pharmaceutical and cosmetic compositions containing themInfo
- Publication number
- IL67995A IL67995A IL67995A IL6799583A IL67995A IL 67995 A IL67995 A IL 67995A IL 67995 A IL67995 A IL 67995A IL 6799583 A IL6799583 A IL 6799583A IL 67995 A IL67995 A IL 67995A
- Authority
- IL
- Israel
- Prior art keywords
- pyrido
- cosmetic compositions
- pharmaceutical
- preparation
- compositions containing
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 title 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000001671 coumarin Nutrition 0.000 abstract 1
- 150000004775 coumarins Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Luminescent Compositions (AREA)
- Dental Preparations (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8203158A FR2521999B1 (fr) | 1982-02-25 | 1982-02-25 | Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL67995A0 IL67995A0 (en) | 1983-06-15 |
| IL67995A true IL67995A (en) | 1986-01-31 |
Family
ID=9271352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL67995A IL67995A (en) | 1982-02-25 | 1983-02-25 | Pyrido(3,4-h)psoralen derivatives,their preparation and pharmaceutical and cosmetic compositions containing them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4465691A (de) |
| EP (1) | EP0088023B1 (de) |
| JP (1) | JPS58189184A (de) |
| AT (1) | ATE24911T1 (de) |
| AU (1) | AU557414B2 (de) |
| DE (1) | DE3369139D1 (de) |
| ES (1) | ES8608522A1 (de) |
| FR (1) | FR2521999B1 (de) |
| IL (1) | IL67995A (de) |
| ZA (1) | ZA831225B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116864A (en) * | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
| EP0935462B1 (de) * | 1996-03-29 | 2005-07-27 | Therakos, Inc. | Behandlung von leukocyten durch photopheresis |
| CA2251624C (en) | 1996-04-09 | 2010-06-08 | Therakos, Inc. | Method for removal of psoralens from biological fluids |
| US5985914A (en) * | 1997-07-10 | 1999-11-16 | Therakos, Inc. | Treatment of inflammatory disorders of the bowel and urinary bladder |
| US6219584B1 (en) | 1999-07-09 | 2001-04-17 | Therakos, Inc. | Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy |
| US8722422B2 (en) | 1999-09-03 | 2014-05-13 | Therakos, Inc. | Uninterrupted flow pump apparatus and method |
| US6495366B1 (en) * | 1999-09-03 | 2002-12-17 | Therakos, Inc. | Uninterrupted flow pump apparatus and method |
| US6793643B1 (en) | 2000-04-21 | 2004-09-21 | Therakos, Inc. | Low extracorporeal volume treatment system |
| US10718028B2 (en) | 2015-04-14 | 2020-07-21 | Case Western Reserve University | Fluorescent probes for abasic site detection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260630A (en) * | 1977-08-29 | 1981-04-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Skin diseases |
-
1982
- 1982-02-25 FR FR8203158A patent/FR2521999B1/fr not_active Expired
-
1983
- 1983-02-23 ZA ZA831225A patent/ZA831225B/xx unknown
- 1983-02-24 ES ES520058A patent/ES8608522A1/es not_active Expired
- 1983-02-24 US US06/469,454 patent/US4465691A/en not_active Expired - Fee Related
- 1983-02-24 AU AU11838/83A patent/AU557414B2/en not_active Expired - Fee Related
- 1983-02-25 AT AT83400400T patent/ATE24911T1/de not_active IP Right Cessation
- 1983-02-25 JP JP58030647A patent/JPS58189184A/ja active Pending
- 1983-02-25 DE DE8383400400T patent/DE3369139D1/de not_active Expired
- 1983-02-25 EP EP83400400A patent/EP0088023B1/de not_active Expired
- 1983-02-25 IL IL67995A patent/IL67995A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES520058A0 (es) | 1983-12-01 |
| US4465691A (en) | 1984-08-14 |
| ES8608522A1 (es) | 1986-07-01 |
| JPS58189184A (ja) | 1983-11-04 |
| EP0088023A2 (de) | 1983-09-07 |
| ZA831225B (en) | 1984-01-25 |
| FR2521999B1 (fr) | 1984-05-25 |
| EP0088023A3 (en) | 1983-11-30 |
| AU1183883A (en) | 1983-09-01 |
| EP0088023B1 (de) | 1987-01-14 |
| IL67995A0 (en) | 1983-06-15 |
| FR2521999A1 (fr) | 1983-08-26 |
| AU557414B2 (en) | 1986-12-18 |
| ATE24911T1 (de) | 1987-01-15 |
| DE3369139D1 (en) | 1987-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA895090B (en) | Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds | |
| AU2005997A (en) | Derivatives of camptothecin for use in treating cancer | |
| AU557414B2 (en) | Pyriodo (3,4-h) psoralens | |
| ZA936611B (en) | Substituted cyclohexane derivatives process for their preparation and the use of the compounds for treating diseases | |
| AU629997B2 (en) | New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them | |
| ES2064461T3 (es) | Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica. | |
| HUT53366A (en) | Process for producing 1,8-benzonaphthyridine derivatives and pharmaceutical compositions comprising same | |
| IL67970A (en) | Pyrido(3,4-c)psroalen derivatives,their preparation and pharmaceutical and cosmetic compositions containing them | |
| HUT49882A (en) | Process for producing new spiro square brackets open chroman-4,4'-imidazolidine square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient | |
| HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof | |
| AU3760489A (en) | Derivatives of cyclic amp as treatment for cancer | |
| DE3362725D1 (en) | Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PT76903A (en) | Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same | |
| ES466168A1 (es) | Procedimiento para la preparacion de nuevos derivados de cromonas dotados de actividad medicamentosa | |
| PT73843A (en) | Benzo<4,5>pyrano<2,3c>pyrroles processes for their preparation and pharmaceutical preparations containing same | |
| SG43191G (en) | Isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HU911895D0 (en) | Process for producing (1-aryl-pyrrolidine-2yl)-methyl-piperazine derivatives and pharmaceutical prepartives containing these compounds | |
| EP0204172A3 (en) | Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use | |
| ZA848779B (en) | (2,3-b)thieno pyrrole derivatives,their process of preparation and the pharmaceutical compositions containing them | |
| IT7967404A0 (it) | Composizioni farmaceutiche contenenti derivati monofunzionali dello psoralene per il trattamento delle affezioni cutanee |